RADX
Live / Registered — Registered (as of 26 Oct 2021)
What this means for you
Registered since 26 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90226491
- Registration number
- 6534475
- Mark type
- Stylized text
- Filed
- 30 Sept 2020
- Published for opposition
- 10 Aug 2021
- Registered
- 26 Oct 2021
- Attorney of record
- Angela Y. Dai
Goods and services
- Class 035 — Advertising and business services: Promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting improvement of clinical laboratory testing technologies for COVID-19 and influenza flu; promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens through support of scientific organizations, research institutions, medical institutions, academic institutions, non-profit organizations, and business entities; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu through support of scientific organizations, research institutions, medical institutions, academic institutions, non-profit organizations, and business entities; promoting collaboration within the scientific, research, medical, academic, and business communities to advance research, development, commercialization, and implementation of testing technologies for pathogens; promoting collaboration within the scientific, research, medical, academic, and business communities to advance research, development, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting collaboration within the technology innovator, clinical testing, regulatory affairs, entrepreneur, business leader, and community leader networks to advance research, development, commercialization, and implementation of testing technologies for pathogens; promoting collaboration within the technology innovator, clinical testing, regulatory affairs, entrepreneur, business leader, and community leader networks to advance research, development, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting community-engaged projects to assess and expand availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting community-engaged projects to assess and expand availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting rapid scale-up of testing technologies for pathogens; promoting rapid scale-up of testing technologies for viruses that cause COVID-19 and influenza flu; promoting increased availability of testing technologies for pathogens; promoting increased availability of testing technologies for viruses that cause COVID-19 and influenza flu; administration and management of research grants; administration of programs for promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens; administration of programs for promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu
- Class 036 — Insurance and financial services: Providing grants and financial support for biomedical research and development; providing grants and financial support for biomedical engineering; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for pathogens; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for viruses; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; providing grants and financial support for community-engaged projects, namely, establishment of clinical research sites and testing centers in underserved and/or vulnerable communities; providing information regarding funding opportunities relating to biomedical and scientific research and developments via a website
- Class 041 — Education and entertainment services: Providing a website featuring blogs, non-downloadable videos, non-downloadable videocasts, and educational presentations in the nature of seminars, forums, and non-downloadable webinars relating to medical, biomedical and scientific research information and distribution of educational materials in connection therewith
- Class 042 — Scientific and technological services: Providing a website featuring medical, biomedical and scientific research information; providing a website featuring news in the field of biomedical and scientific research and developments; providing a website featuring biomedical and scientific research information and developments, namely, dashboards displaying biomedical and scientific research data, information and developments
Owner
- U.S. Department of Health and Human Services, Bethesda, MD, US
- U.S. Department of Health and Human Services, Bethesda, MD, US
- U.S. Department of Health and Human Services, Bethesda, MD, US
Prosecution history
- 26 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 10 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Aug 2021 — PUBLISHED FOR OPPOSITION
- 21 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Jan 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jan 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jan 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Dec 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Dec 2020 — NON-FINAL ACTION E-MAILED
- 21 Dec 2020 — NON-FINAL ACTION WRITTEN
- 21 Dec 2020 — ASSIGNED TO EXAMINER